TORONTO and MONTREAL, Nov. 12, 2024 /CNW/ - A proposed Settlement has been reached on behalf of all individuals in Canada who were prescribed and took ABILIFY® before February 23, 2017 ("ABILIFY® ...
Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback